Wu, T. Et Al. 2002. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy. BONE MARROW TRANSPLANTATION , vol.29, no.12 , 949-956.

Wu, T., Sozen, H., Luo, B., Heuss, N., Kalscheuer, H., Lan, P., ... Sutherland, D.(2002). Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy. BONE MARROW TRANSPLANTATION , vol.29, no.12, 949-956.

Wu, T Et Al. "Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy," BONE MARROW TRANSPLANTATION , vol.29, no.12, 949-956, 2002

Wu, T Et Al. "Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy." BONE MARROW TRANSPLANTATION , vol.29, no.12, pp.949-956, 2002

Wu, T. Et Al. (2002) . "Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy." BONE MARROW TRANSPLANTATION , vol.29, no.12, pp.949-956.

@article{article, author={T Wu Et Al. }, title={Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy}, journal={BONE MARROW TRANSPLANTATION}, year=2002, pages={949-956} }